Paradigm Capital Management Inc Buys Globus Medical Inc, Summit Materials Inc, Calix Inc, Sells Cray Inc, Kratos Defense & Security Solutions Inc, TTM Technologies Inc

• New Purchases: ACLS, SPNE, RDNT, CPRX, COLL, FLXN, OPTN, OMI, SURF,
• Added Positions: GMED, SUM, CALX, TLYS, RBBN, ENS, CAL, INFN, COHU, NPTN, ATRC, KIRK, SCSC, PBI, FRTA, MDRX, INOV, RTIX, SNX, MKSI, NNBR, IIVI, SWKS, TOWR, JILL, FL, CTRN,
• Reduced Positions: CRAY, KTOS, TTMI, UCTT, RCM, LZB, HIVE, FSS, FORM, WAIR, AMWD, DCO, ICHR, LTXB, ENSG, LITE, BMCH, MOD, JBL, HBP, DBI, RXN, RTW, RNST, TIVO, MD, IAC, EW, BRKS, BANR, ATEN, CMCSA, ADUS, ABT,
• Sold Out: EMKR, ETH, FBM, AVP, SRTS, AVNS, MODN, PKOH, TAK, RESN,

For the details of PARADIGM CAPITAL MANAGEMENT INC's stock buys and sells, go to https://www.gurufocus.com/guru/paradigm+capital+management+inc/current-portfolio/portfolioportfolio

1. R1 RCM Inc (RCM) - 5,092,100 shares, 5.84% of the total portfolio. Shares reduced by 9.05%
2. Extreme Networks Inc (EXTR) - 6,778,800 shares, 4.00% of the total portfolio. Shares added by 0.57%
3. Globus Medical Inc (GMED) - 944,700 shares, 3.64% of the total portfolio. Shares added by 28.79%
4. Fabrinet (FN) - 700,800 shares, 3.17% of the total portfolio. Shares added by 0.43%
5. Omnicell Inc (OMCL) - 403,400 shares, 3.16% of the total portfolio. Shares reduced by 0.66%

Paradigm Capital Management Inc initiated holding in Axcelis Technologies Inc. The purchase prices were between $14.06 and $22.08, with an estimated average price of $17.89. The stock is now traded at around $15.22. The impact to a portfolio due to this purchase was 0.1%. The holding were 74,300 shares as of .

Paradigm Capital Management Inc initiated holding in SeaSpine Holdings Corp. The purchase prices were between $12.7 and $15.49, with an estimated average price of $14.01. The stock is now traded at around $12.21. The impact to a portfolio due to this purchase was 0.05%. The holding were 41,000 shares as of .

Paradigm Capital Management Inc initiated holding in RadNet Inc. The purchase prices were between $12.06 and $13.79, with an estimated average price of $12.81. The stock is now traded at around $14.25. The impact to a portfolio due to this purchase was 0.02%. The holding were 17,900 shares as of .

Paradigm Capital Management Inc initiated holding in Catalyst Pharmaceuticals Inc. The purchase prices were between $2.7 and $6.11, with an estimated average price of $4.32. The stock is now traded at around $5.08. The impact to a portfolio due to this purchase was 0.01%. The holding were 20,000 shares as of .

Paradigm Capital Management Inc initiated holding in Owens & Minor Inc. The purchase prices were between $2.69 and $4.16, with an estimated average price of $3.41. The stock is now traded at around $4.53. The impact to a portfolio due to this purchase was 0.01%. The holding were 51,000 shares as of .

Paradigm Capital Management Inc initiated holding in Collegium Pharmaceutical Inc. The purchase prices were between $10.62 and $16.59, with an estimated average price of $13.35. The stock is now traded at around $11.14. The impact to a portfolio due to this purchase was 0.01%. The holding were 10,000 shares as of .

Paradigm Capital Management Inc added to a holding in Globus Medical Inc by 28.79%. The purchase prices were between $39.3 and $48.41, with an estimated average price of $43.39. The stock is now traded at around $49.89. The impact to a portfolio due to this purchase was 0.81%. The holding were 944,700 shares as of .

Paradigm Capital Management Inc added to a holding in Summit Materials Inc by 427.76%. The purchase prices were between $13.69 and $19.25, with an estimated average price of $16.17. The stock is now traded at around $19.46. The impact to a portfolio due to this purchase was 0.57%. The holding were 401,100 shares as of .

Paradigm Capital Management Inc added to a holding in Calix Inc by 969.98%. The purchase prices were between $6.05 and $7.9, with an estimated average price of $6.75. The stock is now traded at around $6.06. The impact to a portfolio due to this purchase was 0.46%. The holding were 855,982 shares as of .

Paradigm Capital Management Inc added to a holding in Tilly's Inc by 108.24%. The purchase prices were between $7.63 and $12.06, with an estimated average price of $10.15. The stock is now traded at around $8.12. The impact to a portfolio due to this purchase was 0.4%. The holding were 1,112,600 shares as of .

Paradigm Capital Management Inc added to a holding in Infinera Corp by 45.34%. The purchase prices were between $2.91 and $5.03, with an estimated average price of $3.77. The stock is now traded at around $4.56. The impact to a portfolio due to this purchase was 0.1%. The holding were 1,198,000 shares as of .

Paradigm Capital Management Inc added to a holding in Cohu Inc by 50.10%. The purchase prices were between $14.44 and $19.21, with an estimated average price of $15.52. The stock is now traded at around $13.43. The impact to a portfolio due to this purchase was 0.08%. The holding were 161,494 shares as of .

Paradigm Capital Management Inc sold out a holding in EMCORE Corp. The sale prices were between $3.29 and $4.16, with an estimated average price of $3.72.

Paradigm Capital Management Inc sold out a holding in Ethan Allen Interiors Inc. The sale prices were between $18.96 and $23.03, with an estimated average price of $21.

Paradigm Capital Management Inc sold out a holding in Foundation Building Materials Inc. The sale prices were between $9.98 and $17.78, with an estimated average price of $14.36.

Paradigm Capital Management Inc sold out a holding in Avon Products Inc. The sale prices were between $2.6 and $4.03, with an estimated average price of $3.33.

Paradigm Capital Management Inc sold out a holding in Sensus Healthcare Inc. The sale prices were between $4.79 and $6.94, with an estimated average price of $5.87.

Paradigm Capital Management Inc sold out a holding in Takeda Pharmaceutical Co Ltd. The sale prices were between $16.58 and $20.49, with an estimated average price of $18.19.